{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:48:24Z","timestamp":1785509304680,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760051"],"award-info":[{"award-number":["81760051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cca.2019.07.019","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T21:58:47Z","timestamp":1563487127000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease"],"prefix":"10.1016","volume":"497","author":[{"given":"Zicong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.07.019_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2009.07.016","article-title":"Innate immune signals in atherosclerosis","volume":"134","author":"Lundberg","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2019.07.019_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.coph.2010.02.003","article-title":"Adaptive T cell immune responses and atherogenesis","volume":"10","author":"Taleb","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cca.2019.07.019_bb0015","doi-asserted-by":"crossref","first-page":"8413768","DOI":"10.1155\/2016\/8413768","article-title":"Il-32: a novel pluripotent inflammatory interleukin, towards gastric inflammation, gastric cancer, and chronic rhino sinusitis","volume":"2016","author":"Khawar","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2019.07.019_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2017.07.005","article-title":"Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases","volume":"264","author":"Damen","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.07.019_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/01902148.2015.1033569","article-title":"Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells","volume":"41","author":"Ota","year":"2015","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.cca.2019.07.019_bb0030","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","article-title":"Il-32-dependent effects of IL-1beta on endothelial cell functions","volume":"106","author":"Nold-Petry","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2019.07.019_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/imm.12374","article-title":"C-Jun nterminal kinase and akt signalling pathways regulating tumour necrosis factoralpha-induced interleukin-32 expression in human lung fibroblasts: implications in airway inflammation","volume":"144","author":"Li","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.cca.2019.07.019_bb0040","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis c virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2019.07.019_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/14397595.2015.1089973","article-title":"Role of interleukin-32 in the mechanism of chronic inflammation in igg4-related disease and as a predictive biomarker for drug-free remission","volume":"26","author":"Shimizu","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cca.2019.07.019_bb0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00296-012-2385-5","article-title":"IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models","volume":"33","author":"Park","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2019.07.019_bb0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1165\/rcmb.2013-0234OC","article-title":"Interleukin-32\u03b3 suppresses allergic airway inflammation in mouse models of asthma","volume":"50","author":"Bang","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cca.2019.07.019_bb0060","doi-asserted-by":"crossref","first-page":"38566","DOI":"10.18632\/oncotarget.6160","article-title":"Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32\u03b2 overexpressed transgenic mice","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2019.07.019_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cyto.2013.05.002","article-title":"Towards a role of interleukin-32 in atherosclerosis","volume":"64","author":"Heinhuis","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2019.07.019_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2017.03.065","article-title":"Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction","volume":"243","author":"Xuan","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2019.07.019_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2017.07.005","article-title":"Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases","volume":"264","author":"Damen","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.07.019_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2017.07.020","article-title":"Sestrins increase in patients with coronary artery disease and associate with the severity of coronary stenosis","volume":"472","author":"Ye","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.07.019_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052490","article-title":"Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.07.019_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2119\/molmed.2014.00195","article-title":"Valsartan attenuates atherosclerosis via upregulating the Th2 immune response in prolonged angiotensin II-treated ApoE(\u2212\/\u2212) mice","volume":"21","author":"Meng","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.cca.2019.07.019_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s12026-017-8939-6","article-title":"Interleukin-10 production and T cell-suppressive capacity in B cell subsets from atherosclerotic apoE \u2212\/\u2212 mice","volume":"65","author":"Rinc\u00f3n-Ar\u00e9valo","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2019.07.019_bb0100","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cca.2019.07.019_bb0105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1159\/000487344","article-title":"Transgenic overexpression of IL-37 protects against atherosclerosis and strengthens plaque stability","volume":"45","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cca.2019.07.019_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An Interleukin-6 receptor antibody suppresses atherosclerosis in Atherogenic mice","volume":"4","author":"Akita","year":"2017","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.cca.2019.07.019_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/cvv110","article-title":"IL-9 aggravates the development of atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"106","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2019.07.019_bb0120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2015.08.006","article-title":"IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice","volume":"242","author":"Rattik","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.07.019_bb0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.07.019_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yjmcc.2014.07.003","article-title":"TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice","volume":"76","author":"Wu","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cca.2019.07.019_bb0135","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.ATV.0000206122.61591.ff","article-title":"Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis","volume":"26","author":"Zhou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.07.019_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.07.019_bb0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yjmcc.2008.04.003","article-title":"Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE (\u2212\/\u2212) mice through modulation of Th1\/Th2 balance","volume":"45","author":"Cheng","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cca.2019.07.019_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE (\u2212\/\u2212) mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2019.07.019_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin. Immunol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119319564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119319564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:49:29Z","timestamp":1757861369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119319564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"alternative-id":["S0009898119319564"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.07.019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}